Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

Delayed Data
As of May 31
 +0.21 / +0.41%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 21 analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of 75.00, with a high estimate of 100.00 and a low estimate of 59.00. The median estimate represents a +44.59% increase from the last price of 51.87.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Buy stock in Teva Pharmaceutical. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.53%
Growthannually -3.08%


Growthquarterly 2.27%
Growthannually 14.95%
Key to the earnings and sales forecast charts.